北米移転した京大発バイオテック Shinobi Therapeutics, Inc.（旧Thyas, Inc.） への投資実行（追加出資、総額74億円ラウンド）のお知らせを英語にすると
[ad_1]
[D3 LLC]
会社発行プレスリリース（英文）
Shinobi Therapeutics Launches with Completion of ＄51M Series A to Advance Hypoimmune iPS-T Cell Therapy Platform
https://www.prnewswire.com/news-releases/shinobi-the...
in English / Investment in Shinobi Therapeutics, Inc. (formerly Thyas, Inc.), a biotech company spun off from Kyoto University and relocated to North America, has been executed (additional investment, total of 7.4 billion yen round).
[D3 LLC]
Company Press Release (English)
Shinobi Therapeutics Launches with Completion of $51M Series A to Advance Hypoimmune iPS-T Cell Therapy Platform
https://www.prnewswire.com/news-releases/shinobi-the...
[ad_2]
Source link